Title: Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.
Journal: Mayo Clinic proceedings 20120401
Title: Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.
Journal: PloS one 20120101
Title: Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Journal: Bioorganic & medicinal chemistry letters 20110915
Title: Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.
Journal: Drug, healthcare and patient safety 20110101
Title: Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
Journal: International journal of antimicrobial agents 20101101
Title: Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci.
Journal: Mini reviews in medicinal chemistry 20100901
Title: Enantioselective synthesis of iclaprim enantiomers--a versatile approach to 2-substituted chiral chromenes.
Journal: The Journal of organic chemistry 20100604
Title: [Update on antimicrobial chemotherapy].
Journal: Medecine et maladies infectieuses 20100301
Title: Future treatment options for Gram-positive infections--looking ahead.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20091201
Title: New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
Journal: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20091201
Title: New treatments for methicillin-resistant Staphylococcus aureus.
Journal: Current opinion in critical care 20091001
Title: [New antibiotics: small or big advances?].
Journal: Der Internist 20091001
Title: Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
Journal: The Journal of infection 20090901
Title: Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Journal: Acta crystallographica. Section D, Biological crystallography 20090801
Title: Antimicrobial development in the era of emerging resistance.
Journal: Mini reviews in medicinal chemistry 20090701
Title: Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
Journal: The Annals of pharmacotherapy 20090601
Title: Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Journal: The Journal of antimicrobial chemotherapy 20090401
Title: New antimicrobial molecules and new antibiotic strategies.
Journal: Seminars in respiratory and critical care medicine 20090401
Title: In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects.
Journal: Diagnostic microbiology and infectious disease 20090301
Title: Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.
Journal: Future microbiology 20090301
Title: Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
Journal: The Journal of antimicrobial chemotherapy 20090201
Title: New antibiotics for healthcare-associated pneumonia.
Journal: Seminars in respiratory and critical care medicine 20090201
Title: Regulatory watch: Non-inferiority-trial discussions impact new drug applications.
Journal: Nature reviews. Drug discovery 20090101
Title: Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit.
Journal: Critical care (London, England) 20090101
Title: New antibiotics for antibiotic-resistant bacteria.
Journal: F1000 biology reports 20090101
Title: The determinants of the antibiotic resistance process.
Journal: Infection and drug resistance 20090101
Title: Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus.
Journal: Infection and drug resistance 20090101
Title: What's new and not so new on the antimicrobial horizon?
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20081201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20081001
Title: Investigational antimicrobial drugs for bloodstream infections.
Journal: Current opinion in investigational drugs (London, England : 2000) 20080801
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080601
Title: Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.
Journal: Current opinion in investigational drugs (London, England : 2000) 20080201
Title: Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.
Journal: Expert review of anti-infective therapy 20080201
Title: A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI).
Journal: Therapeutics and clinical risk management 20080201
Title: Registered and investigational drugs for the treatment of methicillin-resistant Staphylococcus aureus infection.
Journal: Recent patents on anti-infective drug discovery 20080101
Title: [New antimicrobials against Gram-positive organisms].
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101
Title: Current and novel antibiotics against resistant Gram-positive bacteria.
Journal: Infection and drug resistance 20080101
Title: Effect of human plasma on the antimicrobial activity of iclaprim in vitro.
Journal: The Journal of antimicrobial chemotherapy 20071201
Title: In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action.
Journal: The Journal of antimicrobial chemotherapy 20071201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071201
Title: Activity of iclaprim against Legionella pneumophila.
Journal: The Journal of antimicrobial chemotherapy 20071001
Title: Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070915
Title: Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Journal: The Journal of antimicrobial chemotherapy 20070901
Title: Iclaprim.
Journal: Expert opinion on investigational drugs 20070901
Title: Investigational treatments for postoperative surgical site infections.
Journal: Expert opinion on investigational drugs 20070201
Title: Infections associated with orthopedic implants.
Journal: Current opinion in infectious diseases 20060801
Title: Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research.
Journal: IDrugs : the investigational drugs journal 20060601
Title: Dihydrofolate reductase inhibitors as antibacterial agents.
Journal: Biochemical pharmacology 20060330
Title: Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
Journal: Current opinion in microbiology 20051001
Title: Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
Journal: Bioorganic & medicinal chemistry letters 20031201
Title: Schneider P, et al. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Bioorg Med Chem Lett. 2003 Dec 1;13(23):4217-21.
Title: Kohlhoff SA, et al. Iclaprim. Expert Opin Investig Drugs. 2007 Sep;16(9):1441-8.
